tucatinib,olaparib,vemurafenib,larotrectinib,trastuzumab,nivolumab,regorafenib,cobimetinib,temsirolimus,sunitinib,futibatinib,pertuzumab,entrectinib,abemaciclib,palbociclib,pembrolizumab,ipilimumab,talazoparib,atezolizumab
eli lilly,astrazeneca,seagen,bms,roche,merck,bayer,pfizer,otsuka
['breast', 'tapur']
are you a person with breast cancer whose tumor has an abnormal braf gene and your cancer has not responded to standard treatments? talk to your oncologist about s #tapur study. #braf #brafmutation #brafamplification #breast #breastcancer 
Timely, trusted, compassionate doctor-approved info from @ASCO. Signup https://t.co/2KibiNRMFU

We can't answer individual medical questions.

Retweet ≠Endorsement